BRCA1/2 test results impact risk management attitudes, intentions, and uptake-Reference-Cited by-同舟云学术

BRCA1/2 test results impact risk management attitudes, intentions, and uptake

Published:2010-04-10 Issue:3 Volume:124 Page:755-764
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

O’Neill Suzanne C.,Valdimarsdottir Heiddis B.,DeMarco Tiffani A.,Peshkin Beth N.,Graves Kristi D.,Brown Karen,Hurley Karen E.,Isaacs Claudine,Hecker Sharon,Schwartz Marc D.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-010-0881-4.pdf

Reference36 articles.

1. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333

2. Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:136–1310

3. Metcalfe K, Lynch HT, Ghadirian P et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22:2328–2335

4. National Comprehensive Cancer Network (2009) NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. v.1.2009. http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf . Accessed 27 Jan 2010

5. Smith KL, Robson ME (2006) Update on hereditary breast cancer. Curr Oncol Rep 8:14–21

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attitude towards hereditary cancer risk management among women with cancer in Taiwan;Supportive Care in Cancer;2022-01-14

2. Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations;Gynecologic Oncology;2020-02

3. Psychosocial Effects of Multigene Panel Testing in the Context of Cancer Genomics;Hastings Center Report;2019-05

4. Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer;Translational Behavioral Medicine;2018-11-10

5. BRCA Previvors: Medical and Social Factors That Differentiate Them From Previvors With Other Hereditary Cancers;Critical Commentary;2018-04-12